Media Coverage Joni Henderson 8/10/23 Joni Henderson 8/10/23 Being Patient: C₂N’s Alzheimer’s Blood Test in Phil’s Journal Read More Joni Henderson 7/21/23 Joni Henderson 7/21/23 MedPage Today: Alzheimer’s Blood Tests May Improve Primary Care Diagnoses Read More Joni Henderson 7/20/23 Joni Henderson 7/20/23 St. Louis Business Journal award Read More Joni Henderson 7/7/23 Joni Henderson 7/7/23 STAT: We finally have new Alzheimer’s drugs. How do we decide who gets them? Read More Joni Henderson 4/19/23 Joni Henderson 4/19/23 Wall Street Journal: New Blood Tests Offer Possibly Early Detection of Cancer and Alzheimer’s Read More Joni Henderson 4/10/23 Joni Henderson 4/10/23 Fierce BioTech: C₂N’s amyloid- and tau-detecting Alzheimer’s blood test outperforms other screening tests in two studies Read More Joni Henderson 3/30/23 Joni Henderson 3/30/23 Lab Pulse: C₂N Diagnostics announces study confirming accuracy of test for Alzheimer’s diagnosis Read More Guest User 11/17/22 Guest User 11/17/22 Washington Post: Is it Alzheimer’s? Families want to know, and blood tests may offer answers. Read More Guest User 4/29/22 Guest User 4/29/22 USA Today: A new era of diagnosis for Alzheimer's disease': Scientists study blood tests for dementia Read More Joni Henderson 7/21/21 Joni Henderson 7/21/21 Science Magazine: Blood tests could help screen anticipated flood of patients seeking new Alzheimer’s drug Read More Joni Henderson 6/13/21 Joni Henderson 6/13/21 Evaluate Vantage: Aduhelm approval amplifies amyloid assays Read More Joni Henderson 6/11/21 Joni Henderson 6/11/21 360Dx: C₂N Building Case for Alzheimer's Dx as Aducanumab Approval Promises to Impact Testing Space Read More Joni Henderson 6/9/21 Joni Henderson 6/9/21 BioWorld™ MedTech: Approval of aducanumab paves way for Alzheimer’s blood tests Read More Media Coverage 2/15/21 Media Coverage 2/15/21 St. Louis Business Journal: C₂N Diagnostics has brought its Alzheimer’s blood test to market. Now it wants to expand in St. Louis and beyond. Read More Media Coverage 2/7/21 Media Coverage 2/7/21 Barron’s: The Other Pandemic: What to Do About the Coming Alzheimer’s Crisis Read More Media Coverage 2/4/21 Media Coverage 2/4/21 Scientific American: Detecting Alzheimer’s Gets Easier with a Simple Blood Test Read More Media Coverage 1/28/21 Media Coverage 1/28/21 Morning Consult: Blood-Based Diagnostics Will Be Critical to a Comprehensive National Alzheimer’s Response Read More Media Coverage 1/6/21 Media Coverage 1/6/21 MedPage Today: Alzheimer's Blood Tests: Big Breakthroughs in 2020 Read More Media Coverage 12/27/20 Media Coverage 12/27/20 NBCNews.com: COVID-19 wasn’t the only medical story this year. Here’s what you missed in 2020. Read More Media Coverage 12/23/20 Media Coverage 12/23/20 The Scientist: The Biggest Science News in 2020 Read More Newer Posts Older Posts
Joni Henderson 8/10/23 Joni Henderson 8/10/23 Being Patient: C₂N’s Alzheimer’s Blood Test in Phil’s Journal Read More
Joni Henderson 7/21/23 Joni Henderson 7/21/23 MedPage Today: Alzheimer’s Blood Tests May Improve Primary Care Diagnoses Read More
Joni Henderson 7/7/23 Joni Henderson 7/7/23 STAT: We finally have new Alzheimer’s drugs. How do we decide who gets them? Read More
Joni Henderson 4/19/23 Joni Henderson 4/19/23 Wall Street Journal: New Blood Tests Offer Possibly Early Detection of Cancer and Alzheimer’s Read More
Joni Henderson 4/10/23 Joni Henderson 4/10/23 Fierce BioTech: C₂N’s amyloid- and tau-detecting Alzheimer’s blood test outperforms other screening tests in two studies Read More
Joni Henderson 3/30/23 Joni Henderson 3/30/23 Lab Pulse: C₂N Diagnostics announces study confirming accuracy of test for Alzheimer’s diagnosis Read More
Guest User 11/17/22 Guest User 11/17/22 Washington Post: Is it Alzheimer’s? Families want to know, and blood tests may offer answers. Read More
Guest User 4/29/22 Guest User 4/29/22 USA Today: A new era of diagnosis for Alzheimer's disease': Scientists study blood tests for dementia Read More
Joni Henderson 7/21/21 Joni Henderson 7/21/21 Science Magazine: Blood tests could help screen anticipated flood of patients seeking new Alzheimer’s drug Read More
Joni Henderson 6/13/21 Joni Henderson 6/13/21 Evaluate Vantage: Aduhelm approval amplifies amyloid assays Read More
Joni Henderson 6/11/21 Joni Henderson 6/11/21 360Dx: C₂N Building Case for Alzheimer's Dx as Aducanumab Approval Promises to Impact Testing Space Read More
Joni Henderson 6/9/21 Joni Henderson 6/9/21 BioWorld™ MedTech: Approval of aducanumab paves way for Alzheimer’s blood tests Read More
Media Coverage 2/15/21 Media Coverage 2/15/21 St. Louis Business Journal: C₂N Diagnostics has brought its Alzheimer’s blood test to market. Now it wants to expand in St. Louis and beyond. Read More
Media Coverage 2/7/21 Media Coverage 2/7/21 Barron’s: The Other Pandemic: What to Do About the Coming Alzheimer’s Crisis Read More
Media Coverage 2/4/21 Media Coverage 2/4/21 Scientific American: Detecting Alzheimer’s Gets Easier with a Simple Blood Test Read More
Media Coverage 1/28/21 Media Coverage 1/28/21 Morning Consult: Blood-Based Diagnostics Will Be Critical to a Comprehensive National Alzheimer’s Response Read More
Media Coverage 1/6/21 Media Coverage 1/6/21 MedPage Today: Alzheimer's Blood Tests: Big Breakthroughs in 2020 Read More
Media Coverage 12/27/20 Media Coverage 12/27/20 NBCNews.com: COVID-19 wasn’t the only medical story this year. Here’s what you missed in 2020. Read More
Media Coverage 12/23/20 Media Coverage 12/23/20 The Scientist: The Biggest Science News in 2020 Read More
